Cleerly LABS vs Ultrasound Workspace (UWS 6.0)
AI Verdict
Choose Cleerly LABS if…
Choose Cleerly LABS if your primary objective is a detailed, AI-powered analysis of coronary CT angiography (CCTA) scans for comprehensive plaque assessment and stenosis detection. This tool is ideal for quantifying atherosclerosis, characterizing plaque types, and tracking disease progression to inform personalized heart disease management strategies. It provides a precise anatomical understanding crucial for risk stratification and intervention planning.
View Cleerly LABS →Choose Ultrasound Workspace (UWS 6.0) if…
Choose Philips Ultrasound Workspace (UWS 6.0) if you need a holistic, vendor-neutral system to streamline and standardize your echocardiography workflows. This AI-powered solution excels at automating measurements, enhancing diagnostic confidence, and improving reproducibility across various ultrasound machines for comprehensive cardiac functional assessment and reporting. It's best suited for practices seeking efficient and consistent analysis of cardiac ultrasound images.
View Ultrasound Workspace (UWS 6.0) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly LABS | Ultrasound Workspace (UWS 6.0) |
|---|---|---|
| Pricing | Per analysis | Unknown |
| Deployment | Cloud-based (AWS), web-based application, with on-site Cleerly Proxy for data transfer. | On-premise (single-seat workstation, multi-seat server) |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Ultrasound Workspace (UWS 6.0)While both tools offer web-based access, Philips Ultrasound Workspace (UWS 6.0) emphasizes a holistic system with consistent on- and off-cart diagnostic capabilities and web-based access for remote review, analysis, and reporting, suggesting broader flexibility in clinical settings. Its AI-powered automated measurements are designed to streamline time-consuming tasks and improve consistency, directly enhancing workflow efficiency and user experience. Cleerly LABS is also web-based and aims for seamless integration, but UWS 6.0's focus on comprehensive workflow integration across various environments gives it an edge in overall usability.
Clinical Value
Cleerly LABSBoth tools are FDA-cleared and demonstrate significant clinical value. However, Cleerly LABS focuses on a more paradigm-shifting approach by providing comprehensive, AI-driven quantification and characterization of coronary plaque from CCTA, enabling personalized heart disease management and tracking disease progression over time. Clinical studies show it significantly changes clinical decision-making, increases diagnostic confidence, and provides strong prognostic utility for major adverse cardiovascular events (MACE), which is a high-impact clinical outcome. While UWS 6.0 excels in standardizing and improving echocardiography workflows and reproducibility, Cleerly's focus on early, precise disease characterization and risk stratification for CAD offers a potentially greater impact on patient outcomes by aiming to prevent heart attacks.
Pricing & Value
Cleerly LABSCleerly LABS offers transparent pricing per analysis and has achieved a Category I CPT code for plaque analysis with a set reimbursement rate, which significantly enhances its long-term value proposition and accessibility through insurance coverage. In contrast, Philips Ultrasound Workspace (UWS 6.0) requires direct contact for pricing, making it difficult for potential users to assess its cost-effectiveness without engaging a sales representative. The established reimbursement pathway for Cleerly provides a clearer financial benefit and value for healthcare systems and patients.
Enterprise Readiness
Ultrasound Workspace (UWS 6.0)Both tools are HIPAA compliant, FDA-cleared, and integrate with existing hospital systems. However, Philips Ultrasound Workspace (UWS 6.0) stands out with its explicit 'vendor-neutral and multi-vendor data analysis' capability, which is a critical advantage for enterprises needing to standardize workflows across diverse ultrasound equipment from various manufacturers. Its flexible deployment options (on-premise or server-client with web access) and scalable technology platform also cater to a wider range of IT infrastructures and organizational needs, offering robust enterprise-level integration and standardization.
Innovation
Cleerly LABSCleerly LABS demonstrates higher innovation by fundamentally shifting the paradigm of heart disease diagnosis and prevention through its AI-driven comprehensive CCTA analysis for detailed plaque characterization and disease progression tracking, aiming to create a new standard of care. This approach moves beyond traditional methods to enable precision prevention. Its recognition with multiple prestigious AI and HealthTech awards, including 'Best Overall AI Solution' and being named one of TIME's World's Top HealthTech Companies, further underscores its groundbreaking innovation in the field. While UWS 6.0 offers valuable AI-powered automation and vendor neutrality for echocardiography, Cleerly's impact on redefining the diagnostic pathway for CAD is more transformative.
Support & Docs
Ultrasound Workspace (UWS 6.0)Philips, as a large, established healthcare technology company, offers a more extensive and structured support ecosystem for its products, including a dedicated Support Center with various contact options, comprehensive product manuals and resources, and a customer portal (InCenter) for contract-specific documentation and service management. Additionally, Philips provides training and continuous education through its Learning Center, which is crucial for complex medical software. While Cleerly offers client support, the breadth and depth of Philips' established support infrastructure and educational resources provide a more robust offering for enterprise-level deployment and ongoing use.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly LABS | Ultrasound Workspace (UWS 6.0) |
|---|---|---|
| Name | Cleerly LABS | Ultrasound Workspace (UWS 6.0) |
| Company | Cleerly | Philips Ultrasound |
| Description | AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. | Holistic, scalable, AI-powered cardiovascular viewing, analysis, and reporting system designed to streamline echocardiography workflows, enhance diagnostic confidence, and improve reproducibility through vendor-neutral data analysis and flexible deployment. |
| Primary Imaging Modality | Coronary CT Angiography (CCTA) | Echocardiography |
| Key Features (Examples) | AI-powered CCTA image analysis, Comprehensive coronary plaque assessment, Stenosis detection and quantification, Ischemia detection (with Cleerly ISCHEMIA module), Personalized heart disease risk assessment | AI-powered automated measurements (e.g., Auto Measure, AutoStrain LV), Vendor-neutral and multi-vendor data analysis, Comprehensive cardiovascular software solutions (review, image analysis, reporting), Web-based access for remote image review |
Videos
Demos, reviews, and walkthroughs featuring Cleerly LABS and Ultrasound Workspace (UWS 6.0).
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly LABS or Ultrasound Workspace (UWS 6.0)
Backers
Who funded each tool's parent company.